PEE CEE COSMA SOPE
|
PEE CEE COSMA SOPE Last 5 Year Financial Ratios History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 36.31 | 39.47 | 9.40 | 6.37 | 18.01 |
| CEPS(Rs) | 42.48 | 45.52 | 15.10 | 8.86 | 20.23 |
| DPS(Rs) | 3.00 | 5.00 | 2.00 | 1.00 | 3.00 |
| Book NAV/Share(Rs) | 183.54 | 152.23 | 114.77 | 106.37 | 103.00 |
| Tax Rate(%) | 25.54 | 25.69 | 25.40 | 26.30 | 26.01 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 9.26 | 11.49 | 4.16 | 3.02 | 8.12 |
| EBIT Margin(%) | 9.34 | 10.74 | 3.38 | 2.97 | 8.12 |
| Pre Tax Margin(%) | 9.18 | 10.52 | 2.68 | 2.47 | 7.83 |
| PAT Margin (%) | 6.83 | 7.81 | 2.00 | 1.82 | 5.79 |
| Cash Profit Margin (%) | 8.00 | 9.01 | 3.21 | 2.53 | 6.51 |
| Performance Ratios | |||||
| ROA(%) | 18.26 | 22.18 | 5.33 | 4.09 | 14.19 |
| ROE(%) | 21.63 | 29.56 | 8.50 | 6.08 | 19.16 |
| ROCE(%) | 28.85 | 35.14 | 10.25 | 7.62 | 23.07 |
| Asset Turnover(x) | 2.67 | 2.84 | 2.67 | 2.25 | 2.45 |
| Sales/Fixed Asset(x) | 4.48 | 4.39 | 4.20 | 3.70 | 3.94 |
| Working Capital/Sales(x) | 7.26 | 10.97 | 20.20 | 38.52 | 18.85 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.22 | 0.23 | 0.24 | 0.27 | 0.25 |
| Receivable days | 1.27 | 1.43 | 1.71 | 1.81 | 1.57 |
| Inventory Days | 40.36 | 39.38 | 39.58 | 45.96 | 45.93 |
| Payable days | 12.63 | 8.37 | 6.07 | 10.63 | 11.57 |
| Valuation Parameters | |||||
| PER(x) | 14.65 | 9.93 | 10.53 | 19.31 | 6.19 |
| PCE(x) | 12.52 | 8.61 | 6.55 | 13.88 | 5.51 |
| Price/Book(x) | 2.90 | 2.57 | 0.86 | 1.16 | 1.08 |
| Yield(%) | 0.56 | 1.28 | 2.02 | 0.81 | 2.69 |
| EV/Net Sales(x) | 1.01 | 0.78 | 0.29 | 0.48 | 0.40 |
| EV/Core EBITDA(x) | 9.60 | 6.54 | 6.29 | 13.03 | 4.49 |
| EV/EBIT(x) | 10.79 | 7.27 | 8.54 | 16.15 | 4.88 |
| EV/CE(x) | 2.85 | 2.53 | 0.89 | 0.95 | 0.92 |
| M Cap / Sales | 1.00 | 0.78 | 0.21 | 0.35 | 0.36 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 5.20 | 7.33 | 34.33 | 12.69 | 11.24 |
| Core EBITDA Growth(%) | -7.52 | 179.04 | 67.56 | -53.04 | 90.74 |
| EBIT Growth(%) | -8.57 | 241.09 | 52.85 | -58.79 | 118.19 |
| PAT Growth(%) | -7.99 | 320.07 | 47.52 | -64.64 | 126.39 |
| EPS Growth(%) | -7.99 | 320.07 | 47.52 | -64.64 | 126.38 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.02 | 0.02 | 0.33 | 0.48 | 0.12 |
| Current Ratio(x) | 3.29 | 2.72 | 1.59 | 1.20 | 1.53 |
| Quick Ratio(x) | 1.24 | 0.78 | 0.15 | 0.23 | 0.15 |
| Interest Cover(x) | 60.07 | 47.90 | 4.81 | 5.90 | 28.00 |
| Total Debt/Mcap(x) | 0.01 | 0.01 | 0.39 | 0.41 | 0.11 |
Compare Financial Ratios of peers of PEE CEE COSMA SOPE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PEE CEE COSMA SOPE | ₹93.6 Cr | -9.4% | 1.8% | -35.9% | Stock Analytics | |
| HINDUSTAN UNILEVER | ₹544,835.0 Cr | -5.5% | -1.7% | -2.5% | Stock Analytics | |
| GODREJ CONSUMER PRODUCTS | ₹123,163.0 Cr | -0.3% | -2.7% | 9.5% | Stock Analytics | |
| DABUR INDIA | ₹91,247.5 Cr | -1% | 0% | -3% | Stock Analytics | |
| COLGATEPALMOLIVE (INDIA) | ₹57,603.8 Cr | -3.1% | 0.8% | -17.7% | Stock Analytics | |
| PROCTER & GAMBLE HYGIENE AND HEALTH CARE | ₹37,517.1 Cr | -3.3% | -5.6% | -17% | Stock Analytics | |
PEE CEE COSMA SOPE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PEE CEE COSMA SOPE | -9.4% |
1.8% |
-35.9% |
| SENSEX | -0.9% |
-0.1% |
7% |
You may also like the below Video Courses
